|
State Department |
|
|
Programme |
|
|
Sub Programme |
|
|
Allocation: |
KES 23,922,425.00 (R) |
Key Performance Indicators (Targets)
Key Output |
KPI |
Target Yr (2025) |
Target Yr (2026) |
Target Yr (2027) |
|---|---|---|---|---|
Disease Control Services |
No. of patients receiving Anti- Retroviral Therapy ART (Milllions) |
1.37 |
1.37 |
1.37 |
Disease Control Services |
No. of people receiving Artemisinin-Based Combination Therapy ACT (Millions) |
6.1 |
6.5 |
6.7 |
Disease Control Services |
% of Tuberculosis TB patients treated and tested for HIV |
100 |
100 |
100 |
Disease Control Services
No. of patients receiving Anti- Retroviral Therapy ART (Milllions)
2025
1.37
2026
1.37
2027
1.37
Disease Control Services
No. of people receiving Artemisinin-Based Combination Therapy ACT (Millions)
2025
6.1
2026
6.5
2027
6.7
Disease Control Services
% of Tuberculosis TB patients treated and tested for HIV
2025
100
2026
100
2027
100
Previous Year Allocations
Num |
Year |
Total |
|---|---|---|
1 |
KES 23,922,425.00 |
|
2 |
KES 22,520,960.00 |
|
3 |
KES 11,101,456.00 |
|
4 |
KES 6,099,626.00 |
|
5 |
KES 6,269,135.00 |
User Uploads
No. of PPP projects approved: 7
KES 86,537,104.00
KES 83,748,179.00
(2025)
Donor Funds disbursed to MDAs as a % of the external resources mobilized: 100
KES 298,404,302.00
(2025)
No. of staff trained on project appraisal: 30
KES 50,000,000.00
(2025)